The Filing Desk

Editas Medicine vs Septerna

Editas Medicine EDIT · Septerna SEPN · Biotechnology

Septerna reported revenue of $46 million in fiscal 2025, about the same as Editas Medicine's $40 million in fiscal 2025. Editas Medicine's revenue grew 25.4% in its latest year, and Septerna's grew 4174.5%. Editas Medicine had an operating margin of -394.9%, against -148.6% at Septerna. Free cash flow was −$166 million at Editas Medicine and $110 million at Septerna.

Side by side

Editas MedicineSepterna
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$40M$46M
Revenue growth25.4%4,174.5%
Revenue growth a year, last 5 years−14.9%—
Gross margin——
Operating margin−394.9%−148.6%
Net margin−395.0%−106.4%
Free cash flow−$166M$110M
Free cash flow margin−409.3%238.7%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count7.8%347.5%
Last close$2.17$42.60
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score2 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Editas MedicineSepterna
Operating margin
Percent of revenue
Editas MedicineSepterna
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Editas MedicineSepterna

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Editas Medicine and Septerna pages.